SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-261037
Filing Date
2022-10-12
Accepted
2022-10-12 08:12:03
Documents
12
Period of Report
2022-10-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d369459d8k.htm   iXBRL 8-K 24986
  Complete submission text file 0001193125-22-261037.txt   150047

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA dbtx-20221010.xsd EX-101.SCH 2864
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE dbtx-20221010_lab.xml EX-101.LAB 18739
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dbtx-20221010_pre.xml EX-101.PRE 11713
6 EXTRACTED XBRL INSTANCE DOCUMENT d369459d8k_htm.xml XML 3471
Mailing Address 1325 BOYLSTON STREET SUITE 500 BOSTON MA 02215
Business Address 1325 BOYLSTON STREET SUITE 500 BOSTON MA 02215 617-370-8701
Decibel Therapeutics, Inc. (Filer) CIK: 0001656536 (see all company filings)

IRS No.: 464198709 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40030 | Film No.: 221305601
SIC: 2834 Pharmaceutical Preparations